In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rexall Sundown Inc.

Division of Royal Numico NV
www.rexallsundown.com

Latest From Rexall Sundown Inc.

Neurocet Cliff's Notes Fail NAD Test For 'Stronger Than Morphine' Claim

NAD says direct advertising claims for the Neurocet supplement rely on insufficient or ill-fitted research – including summaries – and marketer National Media Group should discontinue numerous statements challenged by the Council for Responsible Nutrition.

United States Dietary Supplements

Health & Wellness Industry Roundup: Week Of July 18

Ortek plots bacteriotherapy path; Puerto Rico proposal under congressional scrutiny; UK pans Special K claim; firms sponsor Olympians; and more news in brief.

United States Dietary Supplements

In Brief: NAD trims BPI claims, formula price-fixing in China, FDA warns Formulife and identifies spiked supplements, NBTY’s consumer redress

BPI discontinues claims at NAD’s behest; China levies fines for infant formula price-fixing; Public Citizen pans OTC Oxytrol; FDA advises ProNatural supplements cannot be topical; FDA warns Formulife on DMAA; FDA uncovers more spiked supplements; NBTY pays back consumers over omega-3 claims; Algean reminded about re-inspection fee.

Consumer China

In Brief: NAD trims BPI claims, formula price-fixing in China, FDA warns Formulife and identifies spiked supplements, NBTY’s consumer redress

BPI discontinues claims at NAD’s behest; China levies fines for infant formula price-fixing; Public Citizen pans OTC Oxytrol; FDA advises ProNatural supplements cannot be topical; FDA warns Formulife on DMAA; FDA uncovers more spiked supplements; NBTY pays back consumers over omega-3 claims; Algean reminded about re-inspection fee.

Consumer China
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Royal Numico NV
  • Senior Management
  • Damon DeSantis, Pres. & CEO
    Geary Cotton, VP, CFO
  • Contact Info
  • Rexall Sundown Inc.
    Phone: (561) 241-9400
    6111 Broken Sound Pkwy. N.W.
    Boca Raton, FL 33487-3693
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register